ClinicalTrials.govpublic full text
Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma
hepatocellular carcinoma, haic, sintilimab, donafenib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 844082
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.